These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21085595)

  • 21. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.
    Coussens LM; Hanahan D; Arbeit JM
    Am J Pathol; 1996 Dec; 149(6):1899-917. PubMed ID: 8952526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
    Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Stroke; 2008 Sep; 39(9):2603-10. PubMed ID: 18635848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.
    Laurent-Matha V; Huesgen PF; Masson O; Derocq D; Prébois C; Gary-Bobo M; Lecaille F; Rebière B; Meurice G; Oréar C; Hollingsworth RE; Abrahamson M; Lalmanach G; Overall CM; Liaudet-Coopman E
    FASEB J; 2012 Dec; 26(12):5172-81. PubMed ID: 22898924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
    Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
    Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.
    Haves-Zburof D; Paperna T; Gour-Lavie A; Mandel I; Glass-Marmor L; Miller A
    J Cell Mol Med; 2011 Nov; 15(11):2421-9. PubMed ID: 21143385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
    Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
    Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
    Helske S; Syväranta S; Lindstedt KA; Lappalainen J; Oörni K; Mäyränpää MI; Lommi J; Turto H; Werkkala K; Kupari M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1791-8. PubMed ID: 16728655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.
    Song S; Pitot HC; Lambert PF
    J Virol; 1999 Jul; 73(7):5887-93. PubMed ID: 10364340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
    Gulliver GA; Herber RL; Liem A; Lambert PF
    J Virol; 1997 Aug; 71(8):5905-14. PubMed ID: 9223480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
    Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
    Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells.
    Hong D; Lu W; Ye F; Hu Y; Xie X
    Br J Cancer; 2009 Nov; 101(10):1798-804. PubMed ID: 19826423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.